2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)RecruitingPhase 32026-10-07NCT06338995
Home Monitoring in eAMD TreatmentExudative Age-Related Macular DegenerationNot yet recruitingNot stated2026-05-06NCT07340372